Chris Van Buren

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 9,487,500 shares of common stock of…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering by Steelcase Inc. of $450 million principal…

Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $5 billion aggregate principal amount of its $700 million aggregate principal…

Davis Polk advised FMC Corporation in connection with the separation of its lithium division into a new publicly traded company, to be called Livent Corporation, and advised Livent in…

Davis Polk advised Entera Bio Ltd. on its initial public offering of 1,400,000 ordinary shares and 1,400,000 warrants to purchase up to 700,000 ordinary shares. In addition, Entera Bio Ltd…

Davis Polk advised the joint book-running managers in connection with an offering by The Bank of N.T. Butterfield & Son Limited of $75 million aggregate principal amount of its 5…

Davis Polk advised the underwriters on a $493.4 million SEC-registered secondary offering of 22,425,000 shares of Class A ordinary shares of Tronox Limited by Exxaro Resources Limited…

Davis Polk advised the underwriter in connection with the $1 billion secondary offering of 14,610,000 shares of common stock of Hilton Worldwide Holdings Inc. by certain selling…

Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by Enova International, Inc. of $250 million aggregate principal amount of 8.500%…

Davis Polk advised the underwriter in connection with the $39.3 million SEC-registered offering of 2,500,000 ordinary shares of Oxford Immunotec Global PLC. The ordinary shares are…